Company News /
by Lauren Evans -
2 years ago
24 Dec 2021 - Medical diagnostic company Universal Biosensors (ASX:UBI) has agreed to be in an exclusive contract with IQ Science to scale a Covid-19 detection test that gives resu…
Market Reports /
by Melissa Darmawan -
3 years ago
10 Aug 2021 - Another mixed closed on major indexes around the globe on mounting fears that Covid-19 cases could derail the pandemic rebound while the oil price slump pressured the…
Market Reports /
by Melissa Darmawan -
3 years ago
15 Jun 2021 - In this report, we cover a wrap up of Wall St’s mixed performance ahead of the Federal Reserve meeting. A weekly overview of the ASX last week, why Universal Biosenso…
Company News /
by Adrian Tan -
3 years ago
26 Apr 2021 - Universal Biosensors (ASX:UBI) has entered into a South African distribution agreement with Vicard SA for its wine-testing "Sentia" device.
Company News /
by Rachael Jones -
3 years ago
30 Dec 2020 - Universal Biosensors, Inc. (ASX:UBI) says its Canadian subsidiary, Hemostasis Reference Laboratory Inc (HRL), has entered into an agreement with Bayer AG of Germany f…
Company News /
by David Chau -
7 years ago
05 Oct 2016 - Universal Biosensors, Inc (ASX:UBI) obtains FDA approval to sell the Xprecia Stride Analyzer device in the US.
Interviews /
by -
8 years ago
29 Oct 2015 - Universal Biosensors (ASX:UBI) CEO Paul Wright discusses the company’s Q3 2015 results and product pipeline.
Market Reports /
by -
10 years ago
17 Sep 2014 - Universal Biosensors, Inc. (ASX:UBI) delays launch of its point-of-care testing system which it’s developing with Siemens Healthcare Diagnostics.
Company Presentations /
by Carolyn Herbert -
10 years ago
27 Feb 2014 - Universal Biosensors Inc (ASX:UBI) CEO Paul Wright presents at ASX Spotlight New York and London about the specialist medical diagnostics company’s operations.
Company News /
by -
12 years ago
27 Jul 2012 - Universal Biosensors Inc. (ASX:UBI) will gain $US1.5 million after securing its second development milestone with Siemens Healthcare Diagnostics.